Gilead Sciences (GILD)

EBITDA Growth

-375.90%

Quarterly · Period ending:

GILD logo

GILD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-375.90%
GILD Quarterly EBITDA YoY % (100.00% → -375.90%)
High-resolution chart · PNG

GILD ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences EBITDA Growth — Quarterly
Period endingEBITDA Growth
-375.904%
16.6987%
-2.8627%
143.259%
13.0697%
173.546%
19.8997%
-41.744%
19.4078%
-263.2258%
-6.8941%
1.5066%
10.0881%
255.1555%
81.7885%
-24.341%
-12.4228%
-79.5925%
-38.9155%
197.387%
208.7248%
15.4647%
0.5613%
256.6372%
-179.3081%
-12.4873%
52.9123%
-127.5107%
11.0044%
10.5597%
-42.1631%
-22.8457%
-42.1615%
-35.7622%
-37.0114%
-11.584%
-4.6436%
-16.8096%
-24.693%
-18.563%
-17.1168%
-11.4114%
28.2536%
58.0283%
26.7437%
73.3313%
252.7951%
206.0807%
280.9962%
197.9218%
11.1584%
10.0301%
9.0059%
31.7197%
22.2001%
1.8624%
1.9791%
-16.4989%
5.4055%
2.5727%
3.1667%
-19.4178%
-19.5631%
10.1758%
29.4082%
45.2396%
43.4863%
37.4632%
25.8124%
18.2183%
51.7494%
24.8486%
17.8607%
25.9815%
5.4244%
32.4323%
47.513%
49.3399%
32.9201%
63.6446%
33.0965%
66.7559%
117.7305%
52.796%
72.9095%
52.7979%
82.4282%
101.4681%
45.6748%
152.1317%
156.3004%
112.593%
398.1792%
1,762.5105%
274.2398%
222.897%
174.7086%
83.9648%
-37.5016%
-77.0336%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.